Augmentin

Medicinal product

(Invented) name

Augmentin

Active substance (s)

Amoksicilinas/Klavulano rūgštis

Strength

875 mg/125 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J01CR02, Amoxicillin and beta-lactamase inhibitor

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2025-01-10

Date of renewal

Documents

2311_Augmentin_875mg125mg_pl_d_tab_N14_PIL.docx

2311_Augmentin_875mg125mg_pl_d_tab_N14_PZ.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Amoksicilinas	875 mg
Klavulano rūgštis	125 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
116158	102258	1102258	lizdinė plokštelė	N14		Receptinis	LT/L/25/2311/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2025-01-10	Registruotas